Civil Society Files Opposition To Monsanto Climate-Related Soybean Patent 03/12/2014 by Catherine Saez, Intellectual Property Watch 2 Comments A civil society coalition is after one of European Monsanto’s patents, accusing the giant seed corporation of biopiracy. The patent granted in February was challenged by the No Patents on Seeds coalition, which filed an opposition a few days ago.
A Middle Path: Advocate-General’s Opinion On Abuse Of Dominance For FRAND-Encumbered SEPs 02/12/2014 by Magda Voltolini for Intellectual Property Watch Leave a Comment For the first time, the European Advocate-General has suggested on the grounds of European competition law the context for negotiations of fair, reasonable and non-discriminatory (FRAND) terms, and has set criteria for the enforcement of injunctions and other remedies in actions involving infringement of standard-essential patents (SEPs). The Court of Justice of the European Union (CJEU) decision is still pending.
EU Law Does Not Adequately Protect Performers, Study Finds 02/12/2014 by Elena Bourtchouladze for Intellectual Property Watch 1 Comment The Association of European Performers’ Organisations (AEPO-ARTIS) has released a study showing that EU legislation does not provide adequate protection to performers for the legal exploitation of their performances on the internet.
Medicines Patent Pool Adds Two AbbVie Paediatric HIV Medicines 01/12/2014 by William New, Intellectual Property Watch 1 Comment The Medicines Patent Pool (MPP) has announced a licence agreement with pharmaceutical manufacturer AbbVie to allow the production of cheaper, more accessible paediatric versions of two HIV medicines.